ReviewBMC pregnancy and childbirth2026
Successful management of a patient with multiple myeloma during pregnancy: a case report and literature review.
Review in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMultiple myeloma (MM) in association with pregnancy is a rare event, and a consensus is lacking. It is urgent to increase the awareness of investigations required for a suspected diagnosis of MM during pregnancy and optimise its management.
methodsA case of MM that occurred during pregnancy is presented with individual details, including clinical presentation, laboratory findings, diagnostic process, natural disease course, therapeutic approaches and outcomes. Afterwards, a literature search was conducted, and the available cases were descriptively reviewed.
resultsA 37-year-old pregnant woman was diagnosed with MM due to anaemia combined with other abnormalities, as revealed by laboratory tests performed during the second trimester. At 27 + 3 weeks gestation, the patient started chemotherapy with cyclophosphamide and methylprednisolone. She delivered a preterm infant via Caesarean section at 28 + 3 weeks gestation and continued to receive anti-myeloma therapy with standard induction postpartum, followed by autologous stem cell transplantation. Both the mother and her offspring achieved favourable outcomes. A total of 52 patients with MM associated with pregnancy aged between 21 and 44 years were identified from a literature review. Ten patients (19.2%) were diagnosed prior to pregnancy, 38 patients (73.1%) were diagnosed during pregnancy, and 4 patients (7.7%) were diagnosed postpartum. The most common initial complaint included bodily pain (53.8%), which was mostly attributed to bone lesions. Among the 48 patients diagnosed with MM before or during pregnancy, 25 patients (52.0%) received chemotherapy during pregnancy. Forty-seven patients (90.4%) delivered healthy infants, and all of them remained symptom-free up to the publication date. Forty-one women (78.8%) remained alive, whereas 10 women (19.2%) died.
conclusionPregnant patients with MM exhibited a broad spectrum of manifestations. Clinicians should raise concerns and be aware of which investigations to request for a suspected diagnosis of MM. Prompt diagnosis in our patient ensured targeted monitoring, and an individualised strategy formulated by a multidisciplinary team allowed for acceptable maternal and foetal outcomes. Currently, multidisciplinary team work-up is preferable for management. The number of agents deemed to be safe for treating MM during pregnancy is fairly limited. Corticosteroids were observed to be the mainstay temporising treatment. Further research should focus on collaborative studies and be designed to assess novel therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.